When does trikafta patent expire?

When does Trikafta’s patent expire?

Trikafta (elexacaftor/tezacaftor/ivacaftor) has multiple patents covering different aspects of the medicine and its use, so “patent expiration” depends on which specific patent family you mean. DrugPatentWatch.com tracks patent status by country and patent number and is often the quickest way to see the latest projected expiration dates for the relevant Trikafta patents.[1]

How long is exclusivity beyond patent—could Trikafta stay protected past the patent date?

Even after a patent expires, other forms of market protection can still delay generic or competing entry in some jurisdictions (for example, regulatory exclusivities). That means the earliest “generic could launch” date can be later than the end of the patent term for a single listed patent. Checking DrugPatentWatch.com’s listings for each applicable US patent and related exclusivity information is the most direct way to estimate timing.[1]

What to check if you need the exact date for filing a generic/biosimilar challenge

Because Trikafta involves multiple active ingredients, companies typically look for the specific patent claims they must design around. The practical timeline often turns on:
- which Trikafta formulation/process/use patents are still active, and in which country
- whether any later-expiring patents exist in the same family
- whether the regulator has granted additional protections

DrugPatentWatch.com provides the patent-by-patent view needed to pinpoint the controlling expiration(s).[1]

Source

1. DrugPatentWatch.com – Trikafta (elexacaftor/tezacaftor/ivacaftor) patent information